Conclusion Of Non-Exclusive Drug Discount Agreements According To § 130A Para. 8 Sgb V By Means Of A So-Called Open House Model For The Active Ingredient Epoetin Zeta (Recombinant Human Erythropoietin)

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 63944846

  Document Type - Tender Notices

Description - The subject of this publication is the conclusion of non-exclusive discount agreements in accordance with Section 130a (8) SGB V for medicinal products containing the active ingredient epoetin zeta (recombinant human erythropoietin). The contract is concluded as part of a so-called open-house model, i. H. A contract is open to all interested pharmaceutical companies within the participation period, provided they meet and accept the participation requirements. As a result, individual contract negotiations are not conducted and (delivery) exclusivity does not exist. It is pointed out that the purchase quantity is unknown, as this depends on demand and the development of the number of insured p

Mt Ref Id - 63944846

Deadline - May 31, 2025